Pancreatic Cancer Global Clinical Trials Review, H1, 2017

GlobalData
1492 Pages - GLDATA62064
$2,500.00

Summary

GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

F. Hoffmann-La Roche Ltd
Novartis AG
Pfizer Inc
Sanofi
AstraZeneca Plc
Celgene Corp
Eli Lilly and Company
Merck & Co Inc
AbbVie Inc
Otsuka Holdings Co Ltd

'

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Pancreatic Cancer Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Pancreatic Cancer 30
Feb 21, 2017: Bellicum Announces Initiation of Patient Dosing with Controllable CAR T-Cell Product Candidate 30
Feb 21, 2017: Spring Bank Pharmaceuticals to Present Results from In Vivo Studies of SB 11285, a Novel STING agonist for Immuno-Oncology, at Keystone Symposia 30
Feb 21, 2017: PharmaCyte Biotech Discusses Patient Enrollment and TD2s Role in Upcoming Clinical Trial 30
Feb 02, 2017: Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients 31
Jan 27, 2017: Redx outlines growing opportunity for Porcupine inhibitors 32
Jan 20, 2017: ARMO BioSciences Presents New Phase 1b Clinical Data for AM0010 in Advanced Pancreatic Cancer Patients at 2017 Gastrointestinal Cancers Symposium 32
Jan 20, 2017: Pamrevlumab Pancreatic Cancer Clinical Data Presented at ASCO 2017 Gastrointestinal Cancers Symposium 33
Jan 20, 2017: ChemoCentryx Announces Presentation of Data from Ongoing Phase Ib Clinical Trial of CCR2 Inhibitor CCX872 in Patients with Advanced Non-Resectable Pancreatic Cancer 33
Jan 17, 2017: BioLineRx Announces Initiation of Immuno-Oncology Phase 2 Study to Investigate Combination of BL-8040 and KEYTRUDA for Pancreatic Cancer 34
Jan 11, 2017: Celyad Announces Registration of the First Pancreatic Cancer Patient in its CAR-T NKR-2THINK Trial in Belgium 35
Jan 05, 2017: Halozyme Announces Phase 2 Study In Advanced Pancreas Cancer Meets Key Endpoints 35
Dec 23, 2016: Anti-AXL Biologic Increases Tumor Sensitivity to Radiation and Check-Point Inhibitors 36
Dec 22, 2016: Propanc Commences GLP-Compliant 28-Day Repeat-Dose Toxicity Study 36
Dec 12, 2016: PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial 36
Clinical Trial Profile Snapshots 38
Appendix 1489
Abbreviations 1489
Definitions 1489
Research Methodology 1490
Secondary Research 1491
About GlobalData 1491
Contact Us 1491
Disclaimer 1492
Source 1492

List of Tables
Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 7
Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13
Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15
Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18
Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures
Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13
Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15
Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18
Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 1490

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports